Xanthine Oxidoreductase Inhibitor Use Associated With Reduced Risk of Sarcopenia and Severe Sarcopenia in Patients Undergoing Hemodialysis.

Front Med (Lausanne) · 2022 · PMC8859856 · PMID 35198574

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

borderline significanceno p-value reported

Furthermore, XOR inhibitor use was shown to be significantly associated with reduced risk of low muscle mass and low physical performance, while a borderline significance with low muscle strength was also found ( Table 2 ).

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.